| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WST | Common Stock | Options Exercise | $230K | +2.44K | +45.42% | $94.27* | 7.81K | Mar 14, 2022 | Direct | |
| transaction | WST | Common Stock | Options Exercise | $465K | +5.58K | +71.38% | $83.47* | 13.4K | Mar 14, 2022 | Direct | |
| transaction | WST | Common Stock | Sale | -$467K | -1.27K | -9.49% | $367.12 | 12.1K | Mar 14, 2022 | Direct | F1 |
| transaction | WST | Common Stock | Sale | -$149K | -405 | -3.34% | $367.94 | 11.7K | Mar 14, 2022 | Direct | F2 |
| transaction | WST | Common Stock | Sale | -$464K | -1.25K | -10.71% | $369.86 | 10.5K | Mar 14, 2022 | Direct | F3 |
| transaction | WST | Common Stock | Sale | -$165K | -446 | -4.26% | $370.94 | 10K | Mar 14, 2022 | Direct | F4 |
| transaction | WST | Common Stock | Sale | -$223K | -600 | -5.99% | $371.89 | 9.41K | Mar 14, 2022 | Direct | F5 |
| transaction | WST | Common Stock | Sale | -$336K | -900 | -9.56% | $372.92 | 8.51K | Mar 14, 2022 | Direct | F6 |
| transaction | WST | Common Stock | Sale | -$1.1M | -2.94K | -34.54% | $374.45 | 5.57K | Mar 14, 2022 | Direct | F7 |
| transaction | WST | Common Stock | Sale | -$75K | -200 | -3.59% | $374.92 | 5.37K | Mar 14, 2022 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WST | Stock Options (Right to buy) | Options Exercise | $0 | -2.44K | -6.58% | $0.00 | 34.6K | Mar 14, 2022 | Common Stock | 2.44K | $94.27 | Direct | |
| transaction | WST | Stock Options (Right to buy) | Options Exercise | $0 | -5.58K | -16.1% | $0.00 | 29.1K | Mar 14, 2022 | Common Stock | 5.58K | $83.47 | Direct |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $366.50 to $367.42, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| F2 | The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $367.56 to $368.22, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| F3 | The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $369.40 to $370.36, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| F4 | The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.41 to $371.32, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| F5 | The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.65 to $372.40, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| F6 | The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $372.70 to $373.46, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| F7 | The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $373.86 to $374.83, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |